Stereotaxis Reports 19% Second Quarter Revenue Growth
ST. LOUIS, Aug. 6 /PRNewswire-FirstCall/ -- Stereotaxis, Inc. (Nasdaq: STXS ) today reported improved financial results for the second quarter ended June 30, 2009. Revenue for the recent second quarter totaled $12.6 million, an increase of 19% over the $10.7 millio...Clarient Reports Second Quarter Revenue Up 40 Percent
ALISO VIEJO, Calif., Aug. 4 /PRNewswire-FirstCall/ -- Clarient, Inc. (Nasdaq: CLRT ), a premier anatomic pathology and molecular testing services resource for pathologists, oncologists and the pharmaceutical industry, today reported financial results for the second quarte...MedPro Scores 87 Percent Sales Revenue Increase in Second Quarter
WAUKESHA, Wis., July 30 /PRNewswire/ -- MedPro Imaging, a premium provider of new and refurbished ultrasound solutions, reported an 87 percent increase in sales revenues for the second quarter of 2009 compared to Q2 2008. The growth was supported by the sale of more than 90 new...Covance Reports Second Quarter Revenue of $466M and EPS of $0.66
PRINCETON, N.J., July 29 /PRNewswire-FirstCall/ -- Covance Inc. (NYSE: CVD ) today reported GAAP earnings for its second quarter ended June 30, 2009 of $0.67 per diluted share, inclusive of a $0.01 per share gain related to the sale of its centralized ECG business in 2007. Excluding ...Endologix Reports 42% Second Quarter 2009 Revenue Growth
IRVINE, Calif., July 22 /PRNewswire-FirstCall/ -- Endologix, Inc. (Nasdaq: ELGX ), developer of minimally invasive treatments for aortic disorders, today announced financial results for the three months ended June 30, 2009. "During the second quarter we continued to be...Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009
..." section below, offset in part, by an increase in revenue recognized in 2009 from Isis' corporate partnerships compared to 2008. Also, Ibis' revenue and expense are included in Isis' 2008 financial r...ppears later in this release. revenue ...2,500 Cases Completed With the Magnetic Irrigated Catheter
...kes no obligation to update these statements for revisions or changes after the date of this release. There can be no assurance that we will recognize revenue related to our purchase orders and other commitments in any particular period or at all because some of these purchase orders and other commitments ar...Nektar Therapeutics Reports Second Quarter 2009 Financial Results
...linical and clinical development programs. revenue for the three month period ended June 30, 2009 was $13.0 million compared to revenue of $20.4 million in the second quarter of 2008. revenue for the first half of 2009 was $22.7 million as co...Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program
...nical studies. Platinum drugs are one of the most clinically and commercially successful class of chemotherapies and generated more than $3 billion in revenue globally in 2008. Access believes that ProLindac, as a well-tolerated and active DACH platinum, represents a important improvement in the design and ...Popular Breast Cancer Drug Used with Certain Antidepressants Puts New Jersey Women at Risk
...th more than 20,000 employees dedicated to improving patient health and reducing costs for a wide range of public and private sector clients, and 2008 revenue exceeding $51 billion, Medco ranks 45th on the Fortune 500 list and is named among the world's most innovative, most admired and most trustworthy comp...Point Of Care Testing (POCT) Information System
Description:... device types from new vendors are deployed through out the hospital. These responsibilities, coupled with the need to capture charges for billing and revenue cost reporting, are increasing the work requirements of the POCT Coordinator to an unrealistic level. POCT accomplishes the goal of rapid turnar...Rising acidity levels could trigger shellfish revenue declines, job losses
Changes in ocean chemistry a consequence of increased carbon dioxide (CO 2 ) emissions from human industrial activity could cause U.S. shellfish revenues to drop significantly in the next 50 years, according to a new study by researchers at the Woods Hole Oceanographic Institution (WHOI). Int...BIO-key(R) Reports Profitability on Strong Revenue Growth for Second Quarter 2008
Achieves record biometric revenues and profitability WALL, N.J., July 28 /PRNewswire-FirstCall/ -- BIO-key International, Inc. (OTC Bulletin Board: BKYI), a leader in wireless public safety and finger-based biometric identification solutions, announced today that it achieved profitab...BIO-key(R) Reports Profitability on Strong Revenue Growth for Second Quarter 2008
Achieves record biometric revenues and profitability WALL, N.J., July 28 /PRNewswire-FirstCall/ -- BIO-key International, Inc. (OTC Bulletin Board: BKYI), a leader in wireless public safety and finger-based biometric identification solutions, announced today that it achieved profitab...Aware, Inc. Reports Second Quarter 2009 Financial Results
...inties, such as estimates or projections of future revenue and earnings and the growth of the DSL and biometr...,852 $3,948 $6,671 $7,872 Contract revenue 1,442 1,776 2,719 3,298 ...--- --- --- --- Total revenue 5,764 6,167 10,337 12,044 ...Bioterrorism and disaster preparedness explored in special issue of Medical Decision Making
...in 17 hours, including such factors as how to best configure the personnel to maximize the number of clients vaccinated; and to estimate the costs and revenue of such an undertaking. The researchers found that it was possible for the clinic to reach its target and that using a computer simulation could help ...OpenQ Posts a 200% Revenue Growth in the First Half of 2009
OpenQ announces solid revenue growth for the first half of 2009 and is now serving 7 of the Top 10 pharmaceutical and 3 of the Top 5 medical device companies. Charlottesville, VA, San Diego, CA, New York, NY and Paris, France (PRWEB) July 18, 2009 -- OpenQ, a leading pr...PDL BioPharma Provides Second Quarter 2009 Revenue Guidance of Approximately $125 Million
INCLINE VILLAGE, Nev., June 8 /PRNewswire-FirstCall/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI ) today announced revenue guidance for the second quarter ended June 30, 2009 of approximately $125 million, as compared with $106 million for the second quarter of 2008. The increase is due pr...Providence Health & Services Increases Revenue by $35 Million Using Concuity ClearContracts
Providence expands use of Concuity products across 16 facilities following success to date increasing net revenue VERNON HILLS, Ill., June 8 /PRNewswire-FirstCall/ -- Concuity, A Healthcare Division of Trintech, Inc. (Nasdaq: TTPA ) announced today that Providence Health & Service...Covance Reports First Quarter Revenue of $441M and EPS of $0.63; Updates Full Year Financial Targets
PRINCETON, N.J., April 29 /PRNewswire-FirstCall/ -- Covance Inc. (NYSE: CVD ) today reported earnings for its first quarter ended March 31, 2009 of $0.63 per diluted share versus $0.76 per diluted share in the first quarter of 2008 (or $0.73 per diluted share after excluding the centralized ECG ...Clarient Reports Strong Revenue Increase for Fourth Quarter and Full-Year 2008
New Molecular Tests and Increasing Case Volumes Drive 78 Percent Revenue Growth in the Fourth Quarter of 2008 as Compared to the Prior Year Period ALISO VIEJO, Calif., March 11 /PRNewswire-FirstCall/ -- Clarient, Inc. (Nasdaq: CLRT ), a premier anatomic pathology and molecular testing ser...